NATIONAL CANCER CONTROL PROGRAMME
NOP online
ISSN 1802-887X
CANCON
 

Oncology news

Sections: Cancer research | Cancer prevention | Czech oncology | NOP On-line project

Archive

Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008


Alarmingly low awareness of urology across Europe
23. 9. 2019 European Association of Urology (EAU) Press Release | More information...

Awareness of prostate health is alarmingly low in men over 50, a new survey [1] commissioned by the European Association of Urology (EAU) has revealed, despite the fact that at the age of 60 and over, 40 percent of men suffer from an enlarged prostate.

Millions of Europeans at risk of chronic digestive diseases, new report reveals
21. 5. 2019 UEG Press Release | More information...

Poor nutritional choices, including a high intake of ultra-processed foods and trans-fats, are putting millions of Europeans at an increased risk of a range of chronic digestive diseases, including digestive cancers, wheat related disorders and functional GI disorders, as well as obesity, a new report shows [1].

Rapid scale-up of HPV vaccine and screening could prevent up to 13 million cases of cervical cancer by 2050
20. 2. 2019 The Lancet | More information...

Cervical cancer could be eliminated as a public health problem in most countries by the end of the century by rapid expansion of existing interventions, according to a modelling study published in The Lancet Oncology journal [1].

New recommendations published: screening intervals and more
4. 2. 2019 ECIBC Press Release | More information...
This World Cancer Day, ECIBC releases 17 new recommendations providing now access to a total of 40 recommendations on breast cancer screening and diagnosis, announced also via the JRC website (EU Science Hub).
EPAD 2019: the current status of prostate cancer screening in EU
30. 1. 2019 European Association of Urology | More information...

After years of decline, prostate cancer mortality has increased last years in several countries. The late detection of advanced prostate cancer, often due to a lack of awareness, is likely a reflection of this revised trend. Although it is well-known that Prostate Specific Antigen (PSA) tests in population-based screening programmes reduce the prostate cancer mortality rate, the discussion on overdiagnosis and overtreatment continues. A good reason for the European Association of Urology (EAU) to publish a policy paper on this topic [1] and invite European influencers to rediscuss the need for population-based prostate cancer screening programmes at a European level during the European Prostate Cancer Awareness Day (EPAD) 2019 [2].


Back